These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 26330151

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle Cells.
    Luo J, Qian A, Oetjen LK, Yu W, Yang P, Feng J, Xie Z, Liu S, Yin S, Dryn D, Cheng J, Riehl TE, Zholos AV, Stenson WF, Kim BS, Hu H.
    Immunity; 2018 Jul 17; 49(1):107-119.e4. PubMed ID: 29958798
    [Abstract] [Full Text] [Related]

  • 4. N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I.
    Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, Chendrimada TP, Lashinger ES, Gordon E, Evans L, Misajet BA, Demarini DJ, Nation JH, Casillas LN, Marquis RW, Votta BJ, Sheardown SA, Xu X, Brooks DP, Laping NJ, Westfall TD.
    J Pharmacol Exp Ther; 2008 Aug 17; 326(2):432-42. PubMed ID: 18499743
    [Abstract] [Full Text] [Related]

  • 5. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
    Zielińska M, Jarmuż A, Wasilewski A, Cami-Kobeci G, Husbands S, Fichna J.
    Pharmacol Rep; 2017 Apr 17; 69(2):350-357. PubMed ID: 28187396
    [Abstract] [Full Text] [Related]

  • 6. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
    Cenac N, Bautzova T, Le Faouder P, Veldhuis NA, Poole DP, Rolland C, Bertrand J, Liedtke W, Dubourdeau M, Bertrand-Michel J, Zecchi L, Stanghellini V, Bunnett NW, Barbara G, Vergnolle N.
    Gastroenterology; 2015 Aug 17; 149(2):433-44.e7. PubMed ID: 25911511
    [Abstract] [Full Text] [Related]

  • 7. Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.
    Sobczak M, Cami-Kobeci G, Sałaga M, Husbands SM, Fichna J.
    Eur J Pharmacol; 2014 Aug 05; 736():63-9. PubMed ID: 24815321
    [Abstract] [Full Text] [Related]

  • 8. Involvement of soluble guanylate cyclase alpha(1) and alpha(2), and SK(Ca) channels in NANC relaxation of mouse distal colon.
    Dhaese I, Vanneste G, Sips P, Buys E, Brouckaert P, Lefebvre RA.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):251-9. PubMed ID: 18572161
    [Abstract] [Full Text] [Related]

  • 9. Effect of nitrergic system on colonic motility in a rat model of irritable bowel syndrome.
    Temiz TK, Demir O, Simsek F, Kaplan YC, Bahceci S, Karadas B, Celik A, Koyluoglu G.
    Indian J Pharmacol; 2016 Jul 28; 48(4):424-429. PubMed ID: 27756955
    [Abstract] [Full Text] [Related]

  • 10. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
    Zielińska M, Chen C, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sałaga M, Małecka-Panas E, Wlaź P, Krajewska WM, Fichna J.
    J Pharm Pharmacol; 2015 Feb 28; 67(2):244-54. PubMed ID: 25515402
    [Abstract] [Full Text] [Related]

  • 11. Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome Is Associated with Upregulation of TMEM16A in Myenteric Plexus.
    Lin MJ, Yu BP.
    Dig Dis Sci; 2018 Dec 28; 63(12):3329-3338. PubMed ID: 30155840
    [Abstract] [Full Text] [Related]

  • 12. Transient Receptor Potential Vanilloid 4 Activation-Induced Increase in Glycine-Activated Current in Mouse Hippocampal Pyramidal Neurons.
    Qi M, Wu C, Wang Z, Zhou L, Men C, Du Y, Huang S, Chen L, Chen L.
    Cell Physiol Biochem; 2018 Dec 28; 45(3):1084-1096. PubMed ID: 29439248
    [Abstract] [Full Text] [Related]

  • 13. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
    Shi HL, Liu CH, Ding LL, Zheng Y, Fei XY, Lu L, Zhou XM, Yuan JY, Xie JQ.
    World J Gastroenterol; 2015 Apr 28; 21(16):4852-63. PubMed ID: 25944998
    [Abstract] [Full Text] [Related]

  • 14. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
    Xu JR, Luo JY, Shang L, Kong WM.
    Chin J Dig Dis; 2006 Apr 28; 7(2):89-96. PubMed ID: 16643336
    [Abstract] [Full Text] [Related]

  • 15. Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome.
    Lin M, Chen L, Xiao Y, Yu B.
    Neurogastroenterol Motil; 2019 Jun 28; 31(6):e13555. PubMed ID: 30793435
    [Abstract] [Full Text] [Related]

  • 16. The effect of transient receptor potential vanilloid 4 on the intestinal epithelial barrier and human colonic cells was affected by tyrosine-phosphorylated claudin-7.
    Huang YY, Li J, Zhang HR, Bai SW, Yang HY, Shen B, Du J, Xia XM.
    Biomed Pharmacother; 2020 Feb 28; 122():109697. PubMed ID: 31918271
    [Abstract] [Full Text] [Related]

  • 17. Extrinsic Primary Afferent Neurons Link Visceral Pain to Colon Motility Through a Spinal Reflex in Mice.
    Smith-Edwards KM, Najjar SA, Edwards BS, Howard MJ, Albers KM, Davis BM.
    Gastroenterology; 2019 Aug 28; 157(2):522-536.e2. PubMed ID: 31075226
    [Abstract] [Full Text] [Related]

  • 18. Transient receptor potential vanilloid 4-dependent calcium influx and ATP release in mouse and rat gastric epithelia.
    Mihara H, Suzuki N, Boudaka AA, Muhammad JS, Tominaga M, Tabuchi Y, Sugiyama T.
    World J Gastroenterol; 2016 Jun 28; 22(24):5512-9. PubMed ID: 27350729
    [Abstract] [Full Text] [Related]

  • 19. The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome.
    Salaga M, Binienda A, Tichkule RB, Thakur GA, Makriyannis A, Storr M, Fichna J.
    Eur J Pharmacol; 2018 Oct 05; 836():34-43. PubMed ID: 30121173
    [Abstract] [Full Text] [Related]

  • 20. Leptin modulates enteric neurotransmission in the rat proximal colon: an in vitro study.
    Florian V, Caroline F, Francis C, Camille S, Fabielle A.
    Regul Pept; 2013 Aug 10; 185():73-8. PubMed ID: 23816465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.